Cancer chemoprevention by carotenoids

Molecules

Volumn 17, Issue 3, 2012, Pages 3202-3242

  Tanaka, Takuji ^a,b   Shnimizu, Masahito ^b   Moriwaki, Hisataka ^b  

^a Cancer Research and Prevention   (Japan)

^b GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cancer chemoprevention; Carotenoids; Mechanisms; Xanthophylls

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; CAROTENOID;

ANIMAL; CHEMISTRY; CHEMOPROPHYLAXIS; CLINICAL TRIAL (TOPIC); DIET; DIET SUPPLEMENTATION; FRUIT; HUMAN; NEOPLASM; REVIEW; VEGETABLE;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; CAROTENOIDS; CHEMOPREVENTION; CLINICAL TRIALS AS TOPIC; DIET; DIETARY SUPPLEMENTS; FRUIT; HUMANS; NEOPLASMS; VEGETABLES;

EID: 84858965591     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules17033202     Document Type: Review

References (255)

1. Sporn, MB.; Suh, N. Chemoprevention of cancer. Carcinogenesis 2000, 21, 525-530. (Pubitemid 30137938)
2. Sporn, MB.; Suh, N. Chemoprevention: An essential approach to controlling cancer. Nat. Rev. Cancer 2002, 2, 537-543. (Pubitemid 37328935)
3. Chesson, A.; Collins, A. Assessment of the role of diet in cancer prevention. Cancer Lett. 1997, 114, 237-245. (Pubitemid 27140123)
4. Tanaka, T. Chemoprevention of human cancer: Biology and therapy. Crit. Rev. Oncol. Hematol. 1997, 25, 139-174. (Pubitemid 27240179)
5. Tanaka, T. Effect of diet on human carcinogenesis. Crit. Rev. Oncol. Hematol. 1997, 25, 73-95. (Pubitemid 27168182)
6. Lee, B. M.; Park, K. K. Beneficial and adverse effects of chemopreventive agents. Mutat. Res. 2003, 523-524, 265-278. (Pubitemid 36293253)
7. Potter, J. D. Cancer prevention: Epidemiology and experiment. Cancer Lett. 1997, 114, 7-9. (Pubitemid 27140065)
8. Wargovich, M. J. Experimental evidence for cancer preventive elements in foods. Cancer Lett. 1997, 114, 11-17. (Pubitemid 27140066)
9. Eastwood, M. A. Interaction of dietary antioxidants in vivo: How fruit and vegetables prevent disease? QJM 1999, 92, 527-530. (Pubitemid 29430051)
10. Holick, C. N.; Michaud, D. S.; Stolzenberg-Solomon, R.; Mayne, S. T.; Pietinen, P.; Taylor, PR.; Virtamo, J.; Albanes, D. Dietary carotenoids, serum β-carotene, and retinol and risk of lung cancer in the α-tocopherol, β-carotene cohort study. Am. J. Epidemiol. 2002, 156, 536-547. (Pubitemid 35001196)
11. Rock, C. L. Carotenoid update. J. Am. Diet Assoc. 2003, 103, 423-425. (Pubitemid 38388123)
12. Zhang, S.; Hunter, D. J.; Forman, MR.; Rosner, B. A.; Speizer, F. E.; Colditz, G. A.; Manson, J. E.; Hankinson, S. E.; Willett, W. C. Dietary carotenoids and vitamins A, C, and E and risk of breast cancer. J. Natl. Cancer Inst. 1999, 91, 547-556. (Pubitemid 29157064)
13. Heinonen, O. P.; Albanes, D. The effect of vitamin E and β carotene on the incidence of lung cancer and other cancers in male smokers. The α-Tocopherol, β Carotene Cancer Prevention Study Group. N Engl. J. Med. 1994, 330, 1029-1035. (Pubitemid 24106559)
14. Hennekens, C. H.; Buring, J. E.; Manson, J. E.; Stampfer, M.; Rosner, B.; Cook, N. R.; Belanger, C.; LaMotte, F.; Gaziano, J. M.; Ridker, P. M.; et al. Lack of effect of long-term supplementation with β carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl. J. Med. 1996, 334, 1145-1149. (Pubitemid 26137972)
15. Omenn, G. S.; Goodman, G. E.; Thornquist, M. D.; Balmes, J.; Cullen, M. R.; Glass, A.; Keogh, J. P.; Meyskens, F. L.; Valanis, B.; Williams, J. H.; et al. Effects of a combination of β carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med. 1996, 334, 1150-1155. (Pubitemid 26137973)
16. Chew, B. P.; Park, J. S.; Wong, M. W.; Wong, T. S. A comparison of the anticancer activities of dietary β-carotene, canthaxanthin and astaxanthin in mice in vivo. Anticancer Res. 1999, 19, 1849-1853. (Pubitemid 29392748)
17. Levy, J.; Bosin, E.; Feldman, B.; Giat, Y.; Miinster, A.; Danilenko, M.; Sharoni, Y. Lycopene is a more potent inhibitor of human cancer cell proliferation than either α-carotene or β-carotene. Nutr. Cancer 1995, 24, 257-266.
18. Murakoshi, M.; Nishino, H.; Satomi, Y.; Takayasu, J.; Hasegawa, T.; Tokuda, H.; Iwashima, A.; Okuzumi, J.; Okabe, H.; Kitano, H.; et al. Potent preventive action of α-carotene against carcinogenesis: Spontaneous liver carcinogenesis and promoting stage of lung and skin carcinogenesis in mice are suppressed more effectively by α-carotene than by β-carotene. Cancer Res. 1992, 52, 6583-6587.
19. Park, J. S.; Chew, B. P.; Wong, T. S. Dietary lutein from marigold extract inhibits mammary tumor development in BALB/c mice. J. Nutr. 1998, 128, 1650-1656. (Pubitemid 28452847)
20. Jalal, F.; Nesheim, M. C.; Agus, Z.; Sanjur, D.; Habicht, J. P. Serum retinol concentrations in children are affected by food sources of β-carotene, fat intake, and anthelmintic drug treatment. Am. J. Clin. Nutr. 1998, 68, 623-629. (Pubitemid 28402385)
21. van Het Hof, K. H.; West, C. E.; Weststrate, J. A.; Hautvast, J. G. Dietary factors that affect the bioavailability of carotenoids. J. Nutr. 2000, 130, 503-506. (Pubitemid 30118062)
22. Clevidence, B. A.; Bieri, J. G. Asociation of carotenoids with human plasma lipoproteins. In Methods in Enzymology; Abelson, J. N., Simon, M. I., Eds.; Academic Press: San Diego, CA, USA, 1993; pp. 33-46.
23. Wang, W.; Connor, S. L.; Johnson, E. J.; Klein, M. L.; Hughes, S.; Connor, W. E. Effect of dietary lutein and zeaxanthin on plasma carotenoids and their transport in lipoproteins in age-related macular degeneration. Am. J. Clin. Nutr. 2007, 85, 762-769. (Pubitemid 46393508)
24. Kotake-Nara, E.; Nagao, A. Absorption and metabolism of xanthophylls. Mar. Drugs 2011, 9, 1024-1037.
25. Nagao, A. Absorption and metabolism of dietary carotenoids. Biofactors 2011, 37, 83-87.
26. Khachik, F.; Spangler, C. J.; Smith, J. C., Jr.; Canfield, L. M.; Steck, A.; Pfander, H. Identification, quantification, and relative concentrations of carotenoids and their metabolites in human milk and serum. Anal. Chem. 1997, 69, 1873-1881.
27. Goodman, D. S.; Huang, H. S. Biosynthesis of vitamin a with rat intestinal enzymes. Science 1965, 149, 879-880.
28. Olson, J. A.; Hayaishi, O. The enzymatic cleavage of β-carotene into vitamin A by soluble enzymes of rat liver and intestine. Proc. Natl. Acad. Sci. USA 1965, 54, 1364-1370.
29. Wang, X. D.; Krinsky, N. I. The bioconversion of β-carotene into retinoids. Subcell. Biochem. 1998, 30, 159-180.
30. Wang, X. D.; Tang, G. W.; Fox, J. G.; Krinsky, N. I.; Russell, R. M. Enzymatic conversion of β-carotene into β-apo-carotenals and retinoids by human, monkey, ferret, and rat tissues. Arch. Biochem. Biophys. 1991, 285, 8-16.
31. Kiefer, C.; Hessel, S.; Lampert, J. M.; Vogt, K.; Lederer, M. O.; Breithaupt, D. E.; von Lintig, J. Identification and characterization of a mammalian enzyme catalyzing the asymmetric oxidative cleavage of provitamin A. J. Biol. Chem. 2001, 276, 14110-14116.
32. Lakshmanan, M. R.; Pope, J. L.; Olson, J. A. The specificity of a partially purified carotenoid cleavage enzyme of rabbit intestine. Biochem. Biophys. Res. Commun. 1968, 33, 347-352.
33. Wang, X. D.; Russell, R. M.; Liu, C.; Stickel, F.; Smith, D. E.; Krinsky, N. I. β-oxidation in rabbit liver in vitro and in the perfused ferret liver contributes to retinoic acid biosynthesis from β-apocarotenoic acids. J. Biol. Chem. 1996, 271, 26490-26498. (Pubitemid 26359046)
34. Ferrucci, L.; Perry, J. R.; Matteini, A.; Perola, M.; Tanaka, T.; Silander, K.; Rice, N.; Melzer, D.; Murray, A.; Cluett, C.; et al. Common variation in the β-carotene 15, 15'-monooxygenase 1 gene affects circulating levels of carotenoids: A genome-wide association study. Am. J. Hum. Genet. 2009, 84, 123-133.
35. Leung, W. C.; Hessel, S.; Meplan, C.; Flint, J.; Oberhauser, V.; Tourniaire, F.; Hesketh, J. E.; von Lintig, J.; Lietz, G. Two common single nucleotide polymorphisms in the gene encoding β-carotene 15, 15'-monoxygenase alter β-carotene metabolism in female volunteers. FASEB J. 2009, 23, 1041-1053.
36. Armstrong, G. A.; Hearst, J. E. Carotenoids 2: Genetics and molecular biology of carotenoid pigment biosynthesis. FASEB J. 1996, 10, 228-237. (Pubitemid 26079942)
37. Demmig-Adams, B.; Gilmore, A. M.; Adams, W. W., 3rd. Carotenoids 3: In vivo function of carotenoids in higher plants. FASEB J. 1996, 10, 403-412. (Pubitemid 26120315)
38. van Breemen, R. B.; Pajkovic, N. Multitargeted therapy of cancer by lycopene. Cancer Lett. 2008, 269, 339-351.
39. Huang, C. S.; Fan, Y. E.; Lin, C. Y.; Hu, M. L. Lycopene inhibits matrix metalloproteinase-9 expression and down-regulates the binding activity of nuclear factor-kappa B and stimulatory protein-1. J. Nutr. Biochem. 2007, 18, 449-456.
40. Huang, C. S.; Liao, J. W.; Hu, M. L. Lycopene inhibits experimental metastasis of human hepatoma SK-Hep-1 cells in athymic nude mice. J. Nutr. 2008, 138, 538-543.
41. Huang, C. S.; Shih, M. K.; Chuang, C. H.; Hu, M. L. Lycopene inhibits cell migration and invasion and upregulates Nm23-H1 in a highly invasive hepatocarcinoma, SK-Hep-1 cells. J. Nutr. 2005, 135, 2119-2123.
42. Yang, C. M.; Yen, Y. T.; Huang, C. S.; Hu, M. L. Growth inhibitory efficacy of lycopene and β-carotene against androgen-independent prostate tumor cells xenografted in nude mice. Mol. Nutr. Food Res. 2011, 55, 606-612.
43. Landrum, J. T.; Bone, R. A. Lutein, zeaxanthin, and the macular pigment. Arch. Biochem. Biophys. 2001, 385, 28-40. (Pubitemid 32988979)
44. Krinsky, N. I.; Landrum, J. T.; Bone, R. A. Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu. Rev. Nutr. 2003, 23, 171-201. (Pubitemid 37059721)
45. Miller, N. J.; Sampson, J.; Candeias, L. P.; Bramley, P. M.; Rice-Evans, C. A. Antioxidant activities of carotenes and xanthophylls. FEBS Lett. 1996, 384, 240-242. (Pubitemid 26125229)
46. di Mascio, P.; Kaiser, S.; Sies, H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch. Biochem. Biophys. 1989, 274, 532-538. (Pubitemid 19261144)
47. Junghans, A.; Sies, H.; Stahl, W. Macular pigments lutein and zeaxanthin as blue light filters studied in liposomes. Arch. Biochem. Biophys. 2001, 391, 160-164. (Pubitemid 32662257)
48. Humphries, J. M.; Khachik, F. Distribution of lutein, zeaxanthin, and related geometrical isomers in fruit, vegetables, wheat, and pasta products. J. Agric. Food. Chem. 2003, 51, 1322-1327.
49. Moeller, S. M.; Jacques, P. F.; Blumberg, J. B. The potential role of dietary xanthophylls in cataract and age-related macular degeneration. J. Am. Coll. Nutr. 2000, 19, 522S-527S.
50. Hadden, W. L.; Watkins, R. H.; Levy, L. W.; Regalado, E.; Rivadeneira, D. M.; van Breemen, R. B.; Schwartz, S. J. Carotenoid composition of marigold (Tagetes erecta) flower extract used as nutritional supplement. J. Agric. Food Chem. 1999, 47, 4189-4194. (Pubitemid 29506223)
51. Nelis, H. J.; de Leenheer, A. P. Microbial sources of carotenoid pigments used in foods and feeds. J. Appl. Bacteriol. 1991, 70, 181-191.
52. Mangels, A. R.; Holden, J. M.; Beecher, G. R.; Forman, M. R.; Lanza, E. Carotenoid content of fruits and vegetables: An evaluation of analytic data. J. Am. Diet Assoc. 1993, 93, 284-296. (Pubitemid 23070877)
53. Sugiura, M.; Matsumoto, H.; Kato, M.; Ikoma, Y.; Yano, M.; Nagao, A. Multiple linear regression analysis of the seasonal changes in the serum concentration of β-cryptoxanthin. J. Nutr. Sci. Vitaminol. (Tokyo) 2004, 50, 196-202. (Pubitemid 39045122)
54. Kaplan, L. A.; Lau, J. M.; Stein, E. A. Carotenoid composition, concentrations, and relationships in various human organs. Clin. Physiol. Biochem. 1990, 8, 1-10. (Pubitemid 20094717)
55. Nair, P. P.; Lohani, A.; Norkus, E. P.; Feagins, H.; Bhagavan, H. N. Uptake and distribution of carotenoids, retinol, and tocopherols in human colonic epithelial cells in vivo. Cancer Epidemiol. Biomark. Prev. 1996, 5, 913-916. (Pubitemid 26382986)
56. Sugiura, M.; Nakamura, M.; Ikoma, Y.; Yano, M.; Ogawa, K.; Matsumoto, H.; Kato, M.; Ohshima, M.; Nagao, A. High serum carotenoids are inversely associated with serum gamma-glutamyltransferase in alcohol drinkers within normal liver function. J. Epidemiol. 2005, 15, 180-186. (Pubitemid 41715794)
57. Sugiura, M.; Nakamura, M.; Ikoma, Y.; Yano, M.; Ogawa, K.; Matsumoto, H.; Kato, M.; Ohshima, M.; Nagao, A. Serum carotenoid concentrations are inversely associated with serum aminotransferases in hyperglycemic subjects. Diabetes Res. Clin. Pract. 2006, 71, 82-91. (Pubitemid 41821147)
58. Nishino, H.; Tokuda, H.; Murakoshi, M.; Satomi, Y.; Masuda, M.; Onozuka, M.; Yamaguchi, S.; Takayasu, J.; Tsuruta, J.; Okuda, M.; et al. Cancer prevention by natural carotenoids. Biofactors 2000, 13, 89-94. (Pubitemid 32107350)
59. Tanaka, T.; Kohno, H.; Murakami, M.; Shimada, R.; Kagami, S.; Sumida, T.; Azuma, Y.; Ogawa, H. Suppression of azoxymethane-induced colon carcinogenesis in male F344 rats by mandarin juices rich in β-cryptoxanthin and hesperidin. Int. J. Cancer 2000, 88, 146-150.
60. Rauscher, R.; Edenharder, R.; Platt, K. L. In vitro antimutagenic and in vivo anticlastogenic effects of carotenoids and solvent extracts from fruits and vegetables rich in carotenoids. Mutat. Res. 1998, 413, 129-142. (Pubitemid 28277072)
61. Sugiura, M.; Nakamura, M.; Ogawa, K.; Ikoma, Y.; Ando, F.; Shimokata, H.; Yano, M. Dietary patterns of antioxidant vitamin and carotenoid intake associated with bone mineral density: Findings from post-menopausal Japanese female subjects. Osteoporos. Int. 2011, 22, 143-152.
62. Sugiura, M.; Ogawa, K.; Yano, M. Effect of chronic administration of fruit extract (Citrus unshiu Marc.) on glucose tolerance in GK rats, a model of type 2 diabetes. Biosci. Biotechnol. Biochem. 2006, 70, 293-295. (Pubitemid 43150994)
63. Uchiyama, S.; Yamaguchi, M. Oral administration of β-cryptoxanthin prevents bone loss in ovariectomized rats. Int. J. Mol. Med. 2006, 17, 15-20.
64. Takayanagi, K. Prevention of adiposity by oral administration of β-cryptoxanthin. Front. Neurol. 2011, 2, 67.
65. Takayanagi, K.; Morimoto, S. I.; Shirakura, Y.; Mukai, K.; Sugiyama, T.; Tokuji, Y.; Ohnishi, M. Mechanism of visceral fat reduction in Tsumura Suzuki Obese, Diabetes (TSOD) mice orally administered β-cryptoxanthin from Satsuma mandarin oranges (Citrus unshiu Marc). J. Agric. Food Chem. 2011, 59, 12342-12351.
66. Katsuura, S.; Imamura, T.; Bando, N.; Yamanishi, R. β-Carotene and β-cryptoxanthin but not lutein evoke redox and immune changes in RAW264 murine macrophages. Mol. Nutr. Food Res. 2009, 53, 1396-1405.
67. Yamaguchi, M.; Weitzmann, M. N. The bone anabolic carotenoid β-cryptoxanthin enhances transforming growth factor-β1-induced SMAD activation in MC3T3 preosteoblasts. Int. J. Mol. Med. 2009, 24, 671-675.
68. Paterson, E.; Gordon, M. H.; Niwat, C.; George, T. W.; Parr, L.; Waroonphan, S.; Lovegrove, J. A. Supplementation with fruit and vegetable soups and beverages increases plasma carotenoid concentrations but does not alter markers of oxidative stress or cardiovascular risk factors. J. Nutr. 2006, 136, 2849-2855. (Pubitemid 44771785)
69. Yuan, J. P.; Peng, J.; Yin, K.; Wang, J. H. Potential health-promoting effects of astaxanthin: A high-value carotenoid mostly from microalgae. Mol. Nutr. Food Res. 2011, 55, 150-165.
70. Pashkow, F. J.; Watumull, D. G.; Campbell, C. L. Astaxanthin: A novel potential treatment for oxidative stress and inflammation in cardiovascular disease. Am. J. Cardiol. 2008, 101, 58D-68D.
71. Hulisz, D. T.; Boles, G. L. Clinical review of canthaxanthin ('tanning pills'). Am. Pharm. 1993, NS33, 44-46. (Pubitemid 23254854)
72. Palozza, P.; Krinsky, N. I. Astaxanthin and canthaxanthin are potent antioxidants in a membrane model. Arch. Biochem. Biophys. 1992, 297, 291-295. (Pubitemid 23282883)
73. Terao, J. Antioxidant activity of β-carotene-related carotenoids in solution. Lipids 1989, 24, 659-661. (Pubitemid 19184263)
74. Zhang, L. X.; Cooney, R. V.; Bertram, J. S. Carotenoids up-regulate connexin43 gene expression independent of their provitamin A or antioxidant properties. Cancer Res. 1992, 52, 5707-5712.
75. Dembitsky, V. M.; Maoka, T. Allenic and cumulenic lipids. Prog. Lipid Res. 2007, 46, 328-375. (Pubitemid 47483947)
76. Nomura, T.; Kikuchi, M.; Kubodera, A.; Kawakami, Y. Proton-donative antioxidant activity of fucoxanthin with 1, 1-diphenyl-2-picrylhydrazyl (DPPH). Biochem. Mol. Biol. Int. 1997, 42, 361-370. (Pubitemid 28297684)
77. Yan, X.; Chuda, Y.; Suzuki, M.; Nagata, T. Fucoxanthin as the major antioxidant in Hijikia fusiformis, a common edible seaweed. Biosci. Biotechnol. Biochem. 1999, 63, 605-607. (Pubitemid 129555518)
78. Woo, M. N.; Jeon, S. M.; Shin, Y. C.; Lee, M. K.; Kang, M. A.; Choi, M. S. Anti-obese property of fucoxanthin is partly mediated by altering lipid-regulating enzymes and uncoupling proteins of visceral adipose tissue in mice. Mol. Nutr. Food Res. 2009, 53, 1603-1611.
79. Beppu, F.; Niwano, Y.; Tsukui, T.; Hosokawa, M.; Miyashita, K. Single and repeated oral dose toxicity study of fucoxanthin (FX), a marine carotenoid, in mice. J. Toxicol. Sci. 2009, 34, 501-510.
80. Iio, K.; Okada, Y.; Ishikura, M. Bacterial reverse mutation test and micronucleus test of fucoxanthin oil from microalgae. Shokuhin Eiseigaku Zasshi 2011, 52, 190-193.
81. Beppu, F.; Niwano, Y.; Sato, E.; Kohno, M.; Tsukui, T.; Hosokawa, M.; Miyashita, K. In vitro and in vivo evaluation of mutagenicity of fucoxanthin (FX) and its metabolite fucoxanthinol (FXOH). J. Toxicol. Sci. 2009, 34, 693-698.
82. Block, G.; Patterson, B.; Subar, A. Fruit, vegetables, and cancer prevention: A review of the epidemiological evidence. Nutr. Cancer 1992, 18, 1-29.
83. Blot, W. J.; Li, J. Y.; Taylor, P. R.; Guo, W.; Dawsey, S.; Wang, G. Q.; Yang, C. S.; Zheng, S. F.; Gail, M.; Li, G. Y.; et al. Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J. Natl. Cancer Inst. 1993, 85, 1483-1492. (Pubitemid 23269183)
84. Ziegler, R. G.; Mayne, S. T.; Swanson, C. A. Nutrition and lung cancer. Cancer Causes Control 1996, 7, 157-177. (Pubitemid 26066853)
85. Wang, X. D.; Russell, R. M. Procarcinogenic and anticarcinogenic effects of β-carotene. Nutr. Rev. 1999, 57, 263-272.
86. Lee, I. M.; Cook, N. R.; Manson, J. E.; Buring, J. E.; Hennekens, C. H. β-Carotene supplementation and incidence of cancer and cardiovascular disease: The women's health study. J. Natl. Cancer Inst. 1999, 91, 2102-2106. (Pubitemid 30019571)
87. Kelloff, G. J.; Boone, C. W.; Crowell, J. A.; Steele, V. E.; Lubet, R. A.; Doody, L. A.; Malone, W. F.; Hawk, E. T.; Sigman, C. C. New agents for cancer chemoprevention. J. Cell. Biochem. Suppl. 1996, 26, 1-28. (Pubitemid 27203750)
88. Tanaka, T. Chemoprevention of oral carcinogenesis. Eur. J. Cancer B Oral Oncol. 1995, 31 B, 3-15.
89. Tanaka, T.; Mori, H. Inhibition of colon carcinogenesis by non-nutritive constituents in foods. J. Toxicol. Pathol. 1996, 9, 139-149.
90. Tanaka, T.; Sugie, S. Inhibition of colon carcinogenesis by dietary non-nutritive compounds. J. Toxicol. Pathol. 2008, 20, 215-235.
91. Davies, K. J. Oxidative stress: The paradox of aerobic life. Biochem. Soc. Symp. 1995, 61, 1-31.
92. Ames, B. N.; Shigenaga, M. K.; Hagen, T. M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA 1993, 90, 7915-7922. (Pubitemid 23260825)
93. Ames, B. N.; Shigenaga, M. K. Oxidants are a major contributor to aging. Ann. N. Y. Acad. Sci. 1992, 663, 85-96. (Pubitemid 23090527)
94. Donaldson, M. S. Nutrition and cancer: A review of the evidence for an anti-cancer diet. Nutr. J. 2004, 3, 19.
95. Tanaka, T.; Makita, H.; Ohnishi, M.; Hirose, Y.; Wang, A.; Mori, H.; Satoh, K.; Hara, A.; Ogawa, H. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary curcumin and hesperidin: comparison with the protective effect of β-carotene. Cancer Res. 1994, 54, 4653-4659.
96. Narisawa, T.; Fukaura, Y.; Hasebe, M.; Ito, M.; Aizawa, R.; Murakoshi, M.; Uemura, S.; Khachik, F.; Nishino, H. Inhibitory effects of natural carotenoids, α-carotene, β-carotene, lycopene and lutein, on colonic aberrant crypt foci formation in rats. Cancer Lett. 1996, 107, 137-142. (Pubitemid 26370869)
97. Faure, H.; Fayol, V.; Galabert, C.; Grolier, P.; Le Moel, G.; Steghens, J. P.; van Kappel, A.; Nabet, F. Carotenoids: 1. Metabolism and physiology. Ann. Biol. Clin. (Paris) 1999, 57, 169-183. (Pubitemid 29158629)
98. Tanaka, T.; Sugiura, H.; Inaba, R.; Nishikawa, A.; Murakami, A.; Koshimizu, K.; Ohigashi, H. Immunomodulatory action of citrus auraptene on macrophage functions and cytokine production of lymphocytes in female BALB/c mice. Carcinogenesis 1999, 20, 1471-1476. (Pubitemid 29385432)
99. Narisawa, T.; Fukaura, Y.; Oshima, S.; Inakuma, T.; Yano, M.; Nishino, H. Chemoprevention by the oxygenated carotenoid β-cryptoxanthin of N-methylnitrosourea-induced colon carcinogenesis in F344 rats. Jpn. J. Cancer Res. 1999, 90, 1061-1065.
100. Kohno, H.; Taima, M.; Sumida, T.; Azuma, Y.; Ogawa, H.; Tanaka, T. Inhibitory effect of mandarin juice rich in β-cryptoxanthin and hesperidin on 4-(methylnitrosamino)-1-(3-pyridyl) - 1-butanone-induced pulmonary tumorigenesis in mice. Cancer Lett. 2001, 174, 141-150. (Pubitemid 33022673)
101. Tanaka, T.; Makita, H.; Kawabata, K.; Mori, H.; Kakumoto, M.; Satoh, K.; Hara, A.; Sumida, T.; Fukutani, K.; Ogawa, H. Modulation of N-methyl-N- amylnitrosamine-induced rat oesophageal tumourigenesis by dietary feeding of diosmin and hesperidin, both alone and in combination. Carcinogenesis 1997, 18, 761-769. (Pubitemid 28132465)
102. Tanaka, T.; Makita, H.; Kawabata, K.; Mori, H.; Kakumoto, M.; Satoh, K.; Hara, A.; Sumida, T.; Ogawa, H. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin. Carcinogenesis 1997, 18, 957-965. (Pubitemid 28132340)
103. Tanaka, T.; Makita, H.; Ohnishi, M.; Hirose, Y.; Wang, A.; Mori, H.; Satoh, K.; Hara, A.; Ogawa, H. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary curcumin and hesperidin: Comparison with the protective effect of β-carotene. Cancer Res. 1994, 54, 4653-4659.
104. Tanaka, T.; Makita, H.; Ohnishi, M.; Mori, H.; Satoh, K.; Hara, A.; Sumida, T.; Fukutani, K.; Ogawa, H. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis in rats by flavonoids diosmin and hesperidin, each alone and in combination. Cancer Res. 1997, 57, 246-252. (Pubitemid 27036601)
105. Yang, M.; Tanaka, T.; Hirose, Y.; Deguchi, T.; Mori, H.; Kawada, Y. Chemopreventive effects of diosmin and hesperidin on N-butyl-N-(4-hydroxybutyl) nitrosamine-induced urinary-bladder carcinogenesis in male ICR mice. Int. J. Cancer 1997, 73, 719-724. (Pubitemid 127483070)
106. Kohno, H.; Maeda, M.; Honjo, S.; Murakami, M.; Shimada, R.; Masuda, S.; Sumida, T.; Azuma, Y.; Ogawa, H.; Tanaka, T. Prevention of colonic preneoplastic lesions by the β-cryptoxanthin and hesperidin rich powder prepared from Citrus unshiu Marc. Juice in male F344 rats. J. Toxicol. Pathol. 1999, 12, 209-215.
107. Tanaka, T.; Tanaka, T.; Tanaka, M.; Kuno, T. Cancer chemoprevention by citrus pulp and juices containing high amounts of β-cryptoxanthin and hesperidin. J. Biomed. Biotechnol. 2012, doi:10.1155/2012/516981.
108. Suzuki, R.; Kohno, H.; Yasui, Y.; Hata, K.; Sugie, S.; Miyamoto, S.; Sugawara, K.; Sumida, T.; Hirose, Y.; Tanaka, T. Diet supplemented with citrus unshiu segment membrane suppresses chemically induced colonic preneoplastic lesions and fatty liver in male db/db mice. Int. J. Cancer 2007, 120, 252-258. (Pubitemid 44956833)
109. Tanaka, T.; Yasui, Y.; Ishigamori-Suzuki, R.; Oyama, T. Citrus compounds inhibit inflammationand obesity-related colon carcinogenesis in mice. Nutr. Cancer 2008, 60, S70-S80.
110. Narisawa, T.; Fukaura, Y.; Hasebe, M.; Nomura, S.; Oshima, S.; Sakamoto, H.; Inakuma, T.; Ishiguro, Y.; Takayasu, J.; Nishino, H. Prevention of N-methylnitrosourea-induced colon carcinogenesis in F344 rats by lycopene and tomato juice rich in lycopene. Jpn. J. Cancer Res. 1998, 89, 1003-1008. (Pubitemid 28544774)
111. Sharoni, Y.; Giron, E.; Rise, M.; Levy, J. Effects of lycopene-enriched tomato oleoresin on 7, 12-dimethyl-benz[a]anthracene-induced rat mammary tumors. Cancer Detect. Prev. 1997, 21, 118-123. (Pubitemid 27176874)
112. Nagasawa, H.; Mitamura, T.; Sakamoto, S.; Yamamoto, K. Effects of lycopene on spontaneous mammary tumour development in SHN virgin mice. Anticancer Res. 1995, 15, 1173-1178.
113. Kim, D. J.; Takasuka, N.; Kim, J. M.; Sekine, K.; Ota, T.; Asamoto, M.; Murakoshi, M.; Nishino, H.; Nir, Z.; Tsuda, H. Chemoprevention by lycopene of mouse lung neoplasia after combined initiation treatment with DEN, MNU and DMH. Cancer Lett. 1997, 120, 15-22. (Pubitemid 27483306)
114. Astorg, P.; Gradelet, S.; Berges, R.; Suschetet, M. Dietary lycopene decreases the initiation of liver preneoplastic foci by diethylnitrosamine in the rat. Nutr. Cancer 1997, 29, 60-68. (Pubitemid 27508126)
115. Okajima, E.; Tsutsumi, M.; Ozono, S.; Akai, H.; Denda, A.; Nishino, H.; Oshima, S.; Sakamoto, H.; Konishi, Y. Inhibitory effect of tomato juice on rat urinary bladder carcinogenesis after N-butyl-N-(4-hydroxybutyl) nitrosamine initiation. Jpn. J. Cancer Res. 1998, 89, 22-26. (Pubitemid 28067506)
116. Cohen, L. A.; Zhao, Z.; Pittman, B.; Khachik, F. Effect of dietary lycopene on N-methylnitrosourea-induced mammary tumorigenesis. Nutr. Cancer 1999, 34, 153-159. (Pubitemid 29511112)
117. Hu, K. Q.; Liu, C.; Ernst, H.; Krinsky, N. I.; Russell, R. M.; Wang, X. D. The biochemical characterization of ferret carotene-9', 10'-monooxygenase catalyzing cleavage of carotenoids in vitro and in vivo. J. Biol. Chem. 2006, 281, 19327-19338. (Pubitemid 44035438)
118. Lian, F.; Smith, D. E.; Ernst, H.; Russell, R. M.; Wang, X. D. Apo-10'-lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo. Carcinogenesis 2007, 28, 1567-1574. (Pubitemid 47241807)
119. Lian, F.; Wang, X. D. Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. Int. J. Cancer 2008, 123, 1262-1268.
120. Yang, C. M.; Huang, S. M.; Liu, C. L.; Hu, M. L. Apo-8'-lycopenal induces expression of HO-1 and NQO-1 via the ERK/p38-Nrf2-ARE pathway in human HepG2 cells. J. Agric. Food Chem. 2012, 60, 1576-7585.
121. Hsing, A. W.; Comstock, G. W.; Abbey, H.; Polk, B. F. Serologic precursors of cancer. Retinol, carotenoids, and tocopherol and risk of prostate cancer. J. Natl. Cancer Inst. 1990, 82, 941-946. (Pubitemid 20176562)
122. Schuurman, A. G.; Goldbohm, R. A.; Brants, H. A.; van den Brandt, P. A. A prospective cohort study on intake of retinol, vitamins C and E, and carotenoids and prostate cancer risk (Netherlands). Cancer Causes Control 2002, 13, 573-582. (Pubitemid 34833109)
123. Giovannucci, E.; Ascherio, A.; Rimm, E. B.; Stampfer, M. J.; Colditz, G. A.; Willett, W. C. Intake of carotenoids and retinol in relation to risk of prostate cancer. J. Natl. Cancer Inst. 1995, 87, 1767-1776.
124. Giovannucci, E.; Rimm, E. B.; Liu, Y.; Stampfer, M. J.; Willett, W. C. A prospective study of tomato products, lycopene, and prostate cancer risk. J. Natl. Cancer Inst. 2002, 94, 391-398. (Pubitemid 34257483)
125. Wu, K.; Erdman, J. W., Jr.; Schwartz, S. J.; Platz, E. A.; Leitzmann, M.; Clinton, S. K.; DeGroff, V.; Willett, W. C.; Giovannucci, E. Plasma and dietary carotenoids, and the risk of prostate cancer: A nested case-control study. Cancer Epidemiol. Biomark. Prev. 2004, 13, 260-269. (Pubitemid 38222558)
126. Kucuk, O.; Sarkar, F. H.; Sakr, W.; Djuric, Z.; Pollak, M. N.; Khachik, F.; Li, Y. W.; Banerjee, M.; Grignon, D.; Bertram, J. S.; et al. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol. Biomark. Prev. 2001, 10, 861-868. (Pubitemid 32738598)
127. Bowen, P.; Chen, L.; Stacewicz-Sapuntzakis, M.; Duncan, C.; Sharifi, R.; Ghosh, L.; Kim, H. S.; Christov-Tzelkov, K.; van Breemen, R. Tomato sauce supplementation and prostate cancer: Lycopene accumulation and modulation of biomarkers of carcinogenesis. Exp. Biol. Med. (Maywood) 2002, 227, 886-893. (Pubitemid 35340343)
128. Cohen, L. A. A review of animal model studies of tomato carotenoids, lycopene, and cancer chemoprevention. Exp. Biol. Med. (Maywood) 2002, 227, 864-868. (Pubitemid 35340340)
129. Michaud, D. S.; Feskanich, D.; Rimm, E. B.; Colditz, G. A.; Speizer, F. E.; Willett, W. C.; Giovannucci, E. Intake of specific carotenoids and risk of lung cancer in 2 prospective US cohorts. Am. J. Clin. Nutr. 2000, 72, 990-997.
130. Le Marchand, L.; Hankin, J. H.; Bach, F.; Kolonel, L. N.; Wilkens, L. R.; Stacewicz-Sapuntzakis, M.; Bowen, P. E.; Beecher, G. R.; Laudon, F.; Baque, P.; et al. An ecological study of diet and lung cancer in the South Pacific. Int. J. Cancer 1995, 63, 18-23.
131. Chew, B. P.; Park, J. S. Carotenoid action on the immune response. J. Nutr. 2004, 134, 257S-261S. (Pubitemid 38057459)
132. Kawashima, T. A marine carotenoid, fucoxanthin, induces regulatory T cells and inhibits Th17 cell differentiation in vitro. Biosci. Biotechnol. Biochem. 2011, 75, 2066-2069.
133. Iannone, A.; Rota, C.; Bergamini, S.; Tomasi, A.; Canfield, L. M. Antioxidant activity of carotenoids: An electron-spin resonance study on β-carotene and lutein interaction with free radicals generated in a chemical system. J. Biochem. Mol. Toxicol. 1998, 12, 299-304. (Pubitemid 128501124)
134. Sujak, A.; Gabrielska, J.; Grudzinski, W.; Borc, R.; Mazurek, P.; Gruszecki, W. I. Lutein and zeaxanthin as protectors of lipid membranes against oxidative damage: The structural aspects. Arch. Biochem. Biophys. 1999, 371, 301-307.
135. Haegele, A. D.; Gillette, C.; O'Neill, C.; Wolfe, P.; Heimendinger, J.; Sedlacek, S.; Thompson, H. J. Plasma xanthophyll carotenoids correlate inversely with indices of oxidative DNA damage and lipid peroxidation. Cancer Epidemiol. Biomark. Prev. 2000, 9, 421-425. (Pubitemid 30265786)
136. Stahl, W.; Junghans, A.; de Boer, B.; Driomina, E. S.; Briviba, K.; Sies, H. Carotenoid mixtures protect multilamellar liposomes against oxidative damage: Synergistic effects of lycopene and lutein. FEBS Lett. 1998, 427, 305-308. (Pubitemid 28225080)
137. Gonzalez de Mejia, E.; Loarca-Pina, G.; Ramos-Gomez, M. Antimutagenicity of xanthophylls present in Aztec Marigold (Tagetes erecta) against 1-nitropyrene. Mutat. Res. 1997, 389, 219-226. (Pubitemid 27227808)
138. Gonzalez de Mejia, E.; Ramos-Gomez, M.; Loarca-Pina, G. Antimutagenic activity of natural xanthophylls against aflatoxin B1 in Salmonella typhimurium. Environ. Mol. Mutagen. 1997, 30, 346-353. (Pubitemid 27491714)
139. Park, J. S.; Chew, B. P.; Wong, T. S.; Zhang, J. X.; Magnuson, N. S. Dietary lutein but not astaxanthin or β-carotene increases pim-1 gene expression in murine lymphocytes. Nutr. Cancer 1999, 33, 206-212. (Pubitemid 29270010)
140. Tsubono, Y.; Tsugane, S.; Gey, K. F. Plasma antioxidant vitamins and carotenoids in five Japanese populations with varied mortality from gastric cancer. Nutr. Cancer 1999, 34, 56-61. (Pubitemid 29382916)
141. Slattery, ML.; Benson, J.; Curtin, K.; Ma, K. N.; Schaeffer, D.; Potter, J. D. Carotenoids and colon cancer. Am. J. Clin. Nutr. 2000, 71, 575-582. (Pubitemid 30061239)
142. Wingerath, T.; Sies, H.; Stahl, W. Xanthophyll esters in human skin. Arch. Biochem. Biophys. 1998, 355, 271-274. (Pubitemid 28364379)
143. Stahl, W.; Heinrich, U.; Jungmann, H.; Sies, H.; Tronnier, H. Carotenoids and carotenoids plus vitamin E protect against ultraviolet light-induced erythema in humans. Am. J. Clin. Nutr. 2000, 71, 795-798. (Pubitemid 30118574)
144. Hunter, D. J.; Manson, J. E.; Colditz, GA.; Stampfer, M. J.; Rosner, B.; Hennekens, C. H.; Speizer, F. E.; Willett, W. C. A prospective study of the intake of vitamins C, E, and A and the risk of breast cancer. N Engl. J. Med. 1993, 329, 234-240. (Pubitemid 23203814)
145. Potischman, N.; McCulloch, C. E.; Byers, T.; Nemoto, T.; Stubbe, N.; Milch, R.; Parker, R.; Rasmussen, KM.; Root, M.; Graham, S.; et al. Breast cancer and dietary and plasma concentrations of carotenoids and vitamin A. Am. J. Clin. Nutr. 1990, 52, 909-915.
146. Rohan, T. E.; McMichael, A. J.; Baghurst, P. A. A population-based case-control study of diet and breast cancer in Australia. Am. J. Epidemiol. 1988, 128, 478-489.
147. Sumantran, V. N.; Zhang, R.; Lee, D. S.; Wicha, M. S. Differential regulation of apoptosis in normal versus transformed mammary epithelium by lutein and retinoic acid. Cancer Epidemiol. Biomark. Prev. 2000, 9, 257-263. (Pubitemid 30165437)
148. Freudenheim, J. L.; Marshall, J. R.; Vena, J. E.; Laughlin, R.; Brasure, J. R.; Swanson, M. K.; Nemoto, T.; Graham, S. Premenopausal breast cancer risk and intake of vegetables, fruits, and related nutrients. J. Natl. Cancer Inst. 1996, 88, 340-348. (Pubitemid 26094240)
149. Dorgan, J. F.; Sowell, A.; Swanson, C. A.; Potischman, N.; Miller, R.; Schussler, N.; Stephenson, H. E., Jr. Relationships of serum carotenoids, retinol, α-tocopherol, and selenium with breast cancer risk: Results from a prospective study in Columbia, Missouri (United States). Cancer Causes Control 1998, 9, 89-97. (Pubitemid 28048664)
150. Zhang, S.; Tang, G.; Russell, R. M.; Mayzel, K. A.; Stampfer, M. J.; Willett, W. C.; Hunter, D. J. Measurement of retinoids and carotenoids in breast adipose tissue and a comparison of concentrations in breast cancer cases and control subjects. Am. J. Clin. Nutr. 1997, 66, 626-632. (Pubitemid 27366788)
151. Toniolo, P.; van Kappel, A. L.; Akhmedkhanov, A.; Ferrari, P.; Kato, I.; Shore, R. E.; Riboli, E. Serum carotenoids and breast cancer. Am. J. Epidemiol. 2001, 153, 1142-1147. (Pubitemid 32552269)
152. Yeum, K. J.; Ahn, S. H.; Rupp de Paiva, S. A.; Lee-Kim, Y. C.; Krinsky, N. I.; Russell, R. M. Correlation between carotenoid concentrations in serum and normal breast adipose tissue of women with benign breast tumor or breast cancer. J. Nutr. 1998, 128, 1920-1926. (Pubitemid 28509855)
153. Anonymous. Eskimo diets and diseases. Lancet 1983, 1, 1139-1141.
154. Bates, C.; van Dam, C.; Horrobin, D. F.; Morse, N.; Huang, Y. S.; Manku, M. S. Plasma essential fatty acids in pure and mixed race American Indians on and off a diet exceptionally rich in salmon. Prostaglandins Leukot. Med. 1985, 17, 77-84. (Pubitemid 15165202)
155. Tanaka, T.; Morishita, Y.; Suzui, M.; Kojima, T.; Okumura, A.; Mori, H. Chemoprevention of mouse urinary bladder carcinogenesis by the naturally occurring carotenoid astaxanthin. Carcinogenesis 1994, 15, 15-19. (Pubitemid 24121618)
156. Tanaka, T.; Makita, H.; Ohnishi, M.; Mori, H.; Satoh, K.; Hara, A. Chemoprevention of rat oral carcinogenesis by naturally occurring xanthophylls, astaxanthin and canthaxanthin. Cancer Res. 1995, 55, 4059-4064.
157. Tanaka, T.; Kawamori, T.; Ohnishi, M.; Makita, H.; Mori, H.; Satoh, K.; Hara, A. Suppression of azoxymethane-induced rat colon carcinogenesis by dietary administration of naturally occurring xanthophylls astaxanthin and canthaxanthin during the postinitiation phase. Carcinogenesis 1995, 16, 2957-2963. (Pubitemid 26004191)
158. Yasui, Y.; Hosokawa, M.; Mikami, N.; Miyashita, K.; Tanaka, T. Dietary astaxanthin inhibits colitis and colitis-associated colon carcinogenesis in mice via modulation of the inflammatory cytokines. Chem. Biol. Interact. 2011, 193, 79-87.
159. McCarty, M. F. Minimizing the cancer-promotional activity of cox-2 as a central strategy in cancer prevention. Med. Hypotheses 2011, 78, 45-57.
160. Nagendraprabhu, P.; Sudhandiran, G. Astaxanthin inhibits tumor invasion by decreasing extracellular matrix production and induces apoptosis in experimental rat colon carcinogenesis by modulating the expressions of ERK-2, NFkB and COX-2. Invest. New Drugs 2011, 29, 207-224.
161. Gradelet, S.; Le Bon, A. M.; Berges, R.; Suschetet, M.; Astorg, P. Dietary carotenoids inhibit aflatoxin B1-induced liver preneoplastic foci and DNA damage in the rat: Role of the modulation of aflatoxin B1 metabolism. Carcinogenesis 1998, 19, 403-411. (Pubitemid 28375441)
162. Hix, L. M.; Frey, D. A.; McLaws, M. D.; Østerlie, M.; Lockwood, S. F.; Bertram, J. S. Inhibition of chemically-induced neoplastic transformation by a novel tetrasodium diphosphate astaxanthin derivative. Carcinogenesis 2005, 26, 1634-1641. (Pubitemid 41236057)
163. Black, H. S.; Mathews-Roth, M. M. Protective role of butylated hydroxytoluene and certain carotenoids in photocarcinogenesis. Photochem. Photobiol. 1991, 53, 707-716.
164. Santamaria, L.; Bianchi, A.; Arnaboldi, A.; Ravetto, C.; Bianchi, L.; Pizzala, R.; Andreoni, L.; Santagati, G.; Bermond, P. Chemoprevention of indirect and direct chemical carcinogenesis by carotenoids as oxygen radical quenchers. Ann. N. Y. Acad. Sci. 1988, 534, 584-596.
165. Grubbs, C. J.; Eto, I.; Juliana, M. M.; Whitaker, L. M. Effect of canthaxanthin on chemically induced mammary carcinogenesis. Oncology 1991, 48, 239-245.
166. Onogi, N.; Okuno, M.; Matsushima-Nishiwaki, R.; Fukutomi, Y.; Moriwaki, H.; Muto, Y.; Kojima, S. Antiproliferative effect of carotenoids on human colon cancer cells without conversion to retinoic acid. Nutr. Cancer 1998, 32, 20-24. (Pubitemid 28519238)
167. Bertram, J. S.; Pung, A.; Churley, M.; Kappock, T. J., IV; Wilkins, L. R.; Cooney, R. V. Diverse carotenoids protect against chemically induced neoplastic transformation. Carcinogenesis 1991, 12, 671-678.
168. Mathews-Roth, M. M.; Krinsky, N. I. Carotenoid dose level and protection against UV-B induced skin tumors. Photochem. Photobiol. 1985, 42, 35-38.
169. Hanusch, M.; Stahl, W.; Schulz, W. A.; Sies, H. Induction of gap junctional communication by 4-oxoretinoic acid generated from its precursor canthaxanthin. Arch. Biochem. Biophys. 1995, 317, 423-428.
170. Gradelet, S.; Astorg, P.; Leclerc, J.; Chevalier, J.; Vernevaut, M. F.; Siess, M. H. Effects of canthaxanthin, astaxanthin, lycopene and lutein on liver xenobiotic-metabolizing enzymes in the rat. Xenobiotica 1996, 26, 49-63. (Pubitemid 26108102)
171. Jewell, C.; O'Brien, N. M. Effect of dietary supplementation with carotenoids on xenobiotic metabolizing enzymes in the liver, lung, kidney and small intestine of the rat. Br. J. Nutr. 1999, 81, 235-242. (Pubitemid 29182189)
172. Palozza, P.; Maggiano, N.; Calviello, G.; Lanza, P.; Piccioni, E.; Ranelletti, F. O.; Bartoli, G. M. Canthaxanthin induces apoptosis in human cancer cell lines. Carcinogenesis 1998, 19, 373-376. (Pubitemid 28375436)
173. Goralczyk, R.; Buser, S.; Bausch, J.; Bee, W.; Zuhlke, U.; Barker, F. M. Occurrence of birefringent retinal inclusions in cynomolgus monkeys after high doses of canthaxanthin. Invest. Ophthalmol. Vis. Sci. 1997, 38, 741-752. (Pubitemid 27143145)
174. Leyon, H.; Ros, A. M.; Nyberg, S.; Algvere, P. Reversibility of canthaxanthin deposits within the retina. Acta Ophthalmol. (Copenh.) 1990, 68, 607-611. (Pubitemid 20373812)
175. Das, S. K.; Hashimoto, T.; Kanazawa, K. Growth inhibition of human hepatic carcinoma HepG2 cells by fucoxanthin is associated with down-regulation of cyclin D. Biochim. Biophys. Acta 2008, 1780, 743-749.
176. Hosokawa, M.; Kudo, M.; Maeda, H.; Kohno, H.; Tanaka, T.; Miyashita, K. Fucoxanthin induces apoptosis and enhances the antiproliferative effect of the PPARgamma ligand, troglitazone, on colon cancer cells. Biochim. Biophys. Acta 2004, 1675, 113-119. (Pubitemid 39463260)
177. Zhang, Z.; Zhang, P.; Hamada, M.; Takahashi, S.; Xing, G.; Liu, J.; Sugiura, N. Potential chemoprevention effect of dietary fucoxanthin on urinary bladder cancer EJ-1 cell line. Oncol. Rep. 2008, 20, 1099-1103.
178. Yonekura, L.; Kobayashi, M.; Terasaki, M.; Nagao, A. Keto-carotenoids are the major metabolites of dietary lutein and fucoxanthin in mouse tissues. J. Nutr. 2010, 140, 1824-1831.
179. Kim, J. M.; Araki, S.; Kim, D. J.; Park, C. B.; Takasuka, N.; Baba-Toriyama, H.; Ota, T.; Nir, Z.; Khachik, F.; Shimidzu, N.; et al. Chemopreventive effects of carotenoids and curcumins on mouse colon carcinogenesis after 1, 2-dimethylhydrazine initiation. Carcinogenesis 1998, 19, 81-85. (Pubitemid 28376829)
180. Nishino, H.; Murakoshi, M.; Tokuda, H.; Satomi, Y. Cancer prevention by carotenoids. Arch. Biochem. Biophys. 2009, 483, 165-168.
181. Okuzumi, J.; Takahashi, T.; Yamane, T.; Kitao, Y.; Inagake, M.; Ohya, K.; Nishino, H.; Tanaka, Y. Inhibitory effects of fucoxanthin, a natural carotenoid, on N-ethyl-N'-nitro-N-nitrosoguanidineinduced mouse duodenal carcinogenesis. Cancer Lett. 1993, 68, 159-168. (Pubitemid 23090674)
182. Yoshiko, S.; Hoyoku, N. Fucoxanthin, a natural carotenoid, induces G1 arrest and GADD45 gene expression in human cancer cells. In Vivo 2007, 21, 305-309. (Pubitemid 46534285)
183. Miyashita, K.; Nishikawa, S.; Beppu, F.; Tsukui, T.; Abe, M.; Hosokawa, M. The allenic carotenoid fucoxanthin, a novel marine nutraceutical from brown seaweeds. J. Sci. Food Agric. 2011, 91, 1166-1174.
184. Liu, C. L.; Huang, Y. S.; Hosokawa, M.; Miyashita, K.; Hu, M. L. Inhibition of proliferation of a hepatoma cell line by fucoxanthin in relation to cell cycle arrest and enhanced gap junctional intercellular communication. Chem. Biol. Interact. 2009, 182, 165-172.
185. Liu, C. L.; Chiu, Y. T.; Hu, M. L. Fucoxanthin enhances HO-1 and NQO1 expression in murine hepatic BNL CL.2 cells through activation of the Nrf2/ARE system partially by its pro-oxidant activity. J. Agric. Food Chem. 2011, 59, 11344-11351.
186. Murakami, C.; Takemura, M.; Sugiyama, Y.; Kamisuki, S.; Asahara, H.; Kawasaki, M.; Ishidoh, T.; Linn, S.; Yoshida, S.; Sugawara, F.; et al. Vitamin A-related compounds, all-trans retinal and retinoic acids, selectively inhibit activities of mammalian replicative DNA polymerases. Biochim. Biophys. Acta 2002, 1574, 85-92. (Pubitemid 34310161)
187. Zhang, L. X.; Cooney, R. V.; Bertram, J. S. Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/10T1/2 cells: relationship to their cancer chemopreventive action. Carcinogenesis 1991, 12, 2109-2114.
188. LeRoith, D.; Roberts, C. T., Jr. The insulin-like growth factor system and cancer. Cancer Lett. 2003, 195, 127-137. (Pubitemid 36588961)
189. Voskuil, D. W.; Vrieling, A.; van't Veer, L. J.; Kampman, E.; Rookus, M. A. The insulin-like growth factor system in cancer prevention: Potential of dietary intervention strategies. Cancer Epidemiol. Biomark. Prev. 2005, 14, 195-203. (Pubitemid 40165303)
190. Mantzoros, C. S.; Tzonou, A.; Signorello, L. B.; Stampfer, M.; Trichopoulos, D.; Adami, H. O. Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. Br. J. Cancer 1997, 76, 1115-1118. (Pubitemid 27448004)
191. Hankinson, S. E.; Willett, W. C.; Colditz, G. A.; Hunter, D. J.; Michaud, D. S.; Deroo, B.; Rosner, B.; Speizer, F. E.; Pollak, M. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998, 351, 1393-1396. (Pubitemid 28209997)
192. Ma, J.; Pollak, M. N.; Giovannucci, E.; Chan, J. M.; Tao, Y.; Hennekens, C. H.; Stampfer, M. J. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J. Natl. Cancer Inst. 1999, 91, 620-625. (Pubitemid 29194048)
193. Yu, H.; Spitz, M. R.; Mistry, J.; Gu, J.; Hong, W. K.; Wu, X. Plasma levels of insulin-like growth factor-I and lung cancer risk: A case-control analysis. J. Natl. Cancer Inst. 1999, 91, 151-156. (Pubitemid 29042692)
194. Min/+ mice exhibit an increased incidence of intestinal neoplasms. Int. J. Mol. Sci. 2011, 12, 8133-8145.
195. Karas, M.; Amir, H.; Fishman, D.; Danilenko, M.; Segal, S.; Nahum, A.; Koifmann, A.; Giat, Y.; Levy, J.; Sharoni, Y. Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. Nutr. Cancer 2000, 36, 101-111. (Pubitemid 30317841)
196. Karas, M.; Danilenko, M.; Fishman, D.; LeRoith, D.; Levy, J.; Sharoni, Y. Membrane-associated insulin-like growth factor-binding protein-3 inhibits insulin-like growth factor-I-induced insulin-like growth factor-I receptor signaling in ishikawa endometrial cancer cells. J. Biol. Chem. 1997, 272, 16514-16520. (Pubitemid 27276479)
197. Amir, H.; Karas, M.; Giat, J.; Danilenko, M.; Levy, R.; Yermiahu, T.; Levy, J.; Sharoni, Y. Lycopene and 1, 25-dihydroxyvitamin D3 cooperate in the inhibition of cell cycle progression and induction of differentiation in HL-60 leukemic cells. Nutr. Cancer 1999, 33, 105-112. (Pubitemid 29196131)
198. Murakoshi, M.; Takayasu, J.; Kimura, O.; Kohmura, E.; Nishino, H.; Iwashima, A.; Okuzumi, J.; Sakai, T.; Sugimoto, T.; Imanishi, J.; et al. Inhibitory effects of α-carotene on proliferation of the human neuroblastoma cell line GOTO. J. Natl. Cancer Inst. 1989, 81, 1649-1652. (Pubitemid 19264048)
199. Stivala, L. A.; Savio, M.; Quarta, S.; Scotti, C.; Cazzalini, O.; Rossi, L.; Scovassi, I. A.; Pizzala, R.; Melli, R.; Bianchi, L.; et al. The antiproliferative effect of β-carotene requires p21waf1/cip1 in normal human fibroblasts. Eur. J. Biochem. 2000, 267, 2290-2296. (Pubitemid 30220075)
200. Satomi, Y.; Nishino, H. Implication of mitogen-activated protein kinase in the induction of G1 cell cycle arrest and gadd45 expression by the carotenoid fucoxanthin in human cancer cells. Biochim. Biophys. Acta 2009, 1790, 260-266.
201. Ford, N. A.; Elsen, AC.; Zuniga, K.; Lindshield, B. L.; Erdman, J. W., Jr. Lycopene and apo-12'-lycopenal reduce cell proliferation and alter cell cycle progression in human prostate cancer cells. Nutr. Cancer 2011, 63, 256-263.
202. Nahum, A.; Hirsch, K.; Danilenko, M.; Watts, C. K.; Prall, O. W.; Levy, J.; Sharoni, Y. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27 (Kip1) in the cyclin E-cdk2 complexes. Oncogene 2001, 20, 3428-3436. (Pubitemid 32588991)
203. Gross, M. D.; Bishop, T. D.; Belcher, J. D.; Jacobs, D. R., Jr. Induction of HL-60 cell differentiation by carotenoids. Nutr. Cancer 1997, 27, 169-173. (Pubitemid 27089691)
204. Tarantilis, P. A.; Morjani, H.; Polissiou, M.; Manfait, M. Inhibition of growth and induction of differentiation of promyelocytc leukemia (HL-60) by carotenoids from Crocus sativus L. Anticancer Res. 1994, 14, 1913-1918.
205. Danilenko, M.; Wang, X.; Studzinski, G. P. Carnosic acid and promotion of monocytic differentiation of HL60-G cells initiated by other agents. J. Natl. Cancer Inst. 2001, 93, 1224-1233. (Pubitemid 32816197)
206. Steiner, M.; Priel, I.; Giat, J.; Levy, J.; Sharoni, Y.; Danilenko, M. Carnosic acid inhibits proliferation and augments differentiation of human leukemic cells induced by 1, 25-dihydroxyvitamin D3 and retinoic acid. Nutr. Cancer 2001, 41, 135-144. (Pubitemid 34666233)
207. Stahl, W.; von Laar, J.; Martin, H. D.; Emmerich, T.; Sies, H. Stimulation of gap junctional communication: Comparison of acyclo-retinoic acid and lycopene. Arch. Biochem. Biophys. 2000, 373, 271-274. (Pubitemid 30046514)
208. Ben-Dor, A.; Nahum, A.; Danilenko, M.; Giat, Y.; Stahl, W.; Martin, H. D.; Emmerich, T.; Noy, N.; Levy, J.; Sharoni, Y. Effects of acyclo-retinoic acid and lycopene on activation of the retinoic acid receptor and proliferation of mammary cancer cells. Arch. Biochem. Biophys. 2001, 391, 295-302. (Pubitemid 32662272)
209. Muto, Y.; Moriwaki, H.; Omori, M. In vitro binding affinity of novel synthetic polyprenoids (polyprenoic acids) to cellular retinoid-binding proteins. Gann 1981, 72, 974-977. (Pubitemid 12172470)
210. Araki, H.; Shidoji, Y.; Yamada, Y.; Moriwaki, H.; Muto, Y. Retinoid agonist activities of synthetic geranyl geranoic acid derivatives. Biochem. Biophys. Res. Commun. 1995, 209, 66-72.
211. Butler, R.; Mitchell, S. H.; Tindall, D. J.; Young, C. Y. Nonapoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor gamma ligand, 15-deoxy-delta12, 14-prostaglandin J2. Cell Growth Differ. 2000, 11, 49-61. (Pubitemid 30078666)
212. Kubota, T.; Koshizuka, K.; Williamson, E. A.; Asou, H.; Said, J. W.; Holden, S.; Miyoshi, I.; Koeffler, H. P. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. Cancer Res. 1998, 58, 3344-3352. (Pubitemid 28371075)
213. Mueller, E.; Smith, M.; Sarraf, P.; Kroll, T.; Aiyer, A.; Kaufman, D. S.; Oh, W.; Demetri, G.; Figg, W. D.; Zhou, X. P.; et al. Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer. Proc. Natl. Acad. Sci. USA 2000, 97, 10990-10995.
214. Yasui, Y.; Kim, M.; Tanaka, T. PPAR Ligands for Cancer Chemoprevention. PPAR Res. 2008, 2008, 548919.
215. Jaiswal, A. K. Regulation of genes encoding NAD (P) H: quinone oxidoreductases. Free Radic. Biol. Med. 2000, 29, 254-262.
216. Venugopal, R.; Jaiswal, A. K. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD (P) H: quinone oxidoreductase1 gene. Proc. Natl. Acad. Sci. USA 1996, 93, 14960-14965. (Pubitemid 26419078)
217. Wang, X. D.; Liu, C.; Bronson, R. T.; Smith, D. E.; Krinsky, N. I.; Russell, M. Retinoid signaling and activator protein-1 expression in ferrets given β-carotene supplements and exposed to tobacco smoke. J. Natl. Cancer Inst. 1999, 91, 60-66. (Pubitemid 29042444)
218. Xie, W.; Evans, R. M. Orphan nuclear receptors: The exotics of xenobiotics. J. Biol. Chem. 2001, 276, 37739-37742.
219. Altucci, L.; Gronemeyer, H. The promise of retinoids to fight against cancer. Nat. Rev. Cancer 2001, 1, 181-193. (Pubitemid 33741893)
220. Pavan, B.; Biondi, C.; Dalpiaz, A. Nuclear retinoic acid receptor β as a tool in chemoprevention trials. Curr. Med. Chem. 2006, 13, 3553-3563. (Pubitemid 44873746)
221. db mice. Cancer Prev. Res. (Phila.) 2011, 4, 128-136.
222. Moriwaki, H.; Shimizu, M.; Okuno, M.; Nishiwaki-Matsushima, R. Chemoprevention of liver carcinogenesis with retinoids: Basic and clinical aspects. Hepatol. Res. 2007, 37, S299-S302.
223. Fabricius, E. M.; Kruse-Boitschenko, U.; Schneeweiss, U.; Wildner, G. P.; Hoffmeister, B.; Raguse, J. D. Model examination of chemoprevention with retinoids in squamous cell carcinomas of the head and neck region and suitable biomarkers for chemoprevention. Int. J. Oncol. 2011, 39, 1083-1097.
224. Prakash, P.; Liu, C.; Hu, K. Q.; Krinsky, N. I.; Russell, R. M.; Wang, X. D. β-Carotene and β-apo-14'-carotenoic acid prevent the reduction of retinoic acid receptor β in benzo[a]pyrene-treated normal human bronchial epithelial cells. J. Nutr. 2004, 134, 667-673. (Pubitemid 38298514)
225. Reuter, S.; Gupta, S. C.; Chaturvedi, M. M.; Aggarwal, B. B. Oxidative stress, inflammation, and cancer: How are they linked? Free Radic. Biol. Med. 2010, 49, 1603-1616.
226. Schmidt, M. V.; Brune, B.; von Knethen, A. The nuclear hormone receptor PPARgamma as a therapeutic target in major diseases. Scientific World Journal 2010, 10, 2181-2197.
227. Youssef, J.; Badr, M. Peroxisome proliferator-activated receptors and cancer: Challenges and opportunities. Br. J. Pharmacol. 2011, 164, 68-82.
228. Sarraf, P.; Mueller, E.; Smith, W. M.; Wright, H. M.; Kum, J. B.; Aaltonen, L. A.; de la Chapelle, A.; Spiegelman, B. M.; Eng, C. Loss-of-function mutations in PPAR gamma associated with human colon cancer. Mol. Cell 1999, 3, 799-804. (Pubitemid 29323058)
229. Simone, R. E.; Russo, M.; Catalano, A.; Monego, G.; Froehlich, K.; Boehm, V.; Palozza, P. Lycopene inhibits NF-κB-mediated IL-8 expression and changes redox and PPARgamma signalling in cigarette smoke-stimulated macrophages. PLoS One 2011, 6, e19652.
230. Yang, CM.; Lu, I. H.; Chen, H. Y.; Hu, M. L. Lycopene inhibits the proliferation of androgen-dependent human prostate tumor cells through activation of PPARγ-LXRα-ABCA1 pathway. J. Nutr. Biochem. 2012, 23, 8-17.
231. Xie, W.; Barwick, J. L.; Simon, CM.; Pierce, A. M.; Safe, S.; Blumberg, B.; Guzelian, PS.; Evans, R. M. Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR. Genes Dev. 2000, 14, 3014-3023.
232. Moore, L. B.; Goodwin, B.; Jones, S. A.; Wisely, G. B.; Serabjit-Singh, C. J.; Willson, T. M.; Collins, J. L.; Kliewer, S. A. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc. Natl. Acad. Sci. USA 2000, 97, 7500-7502. (Pubitemid 30431492)
233. Ramos-Gomez, M.; Kwak, M. K.; Dolan, P. M.; Itoh, K.; Yamamoto, M.; Talalay, P.; Kensler, T. W. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc. Natl. Acad. Sci. USA 2001, 98, 3410-3415. (Pubitemid 32220859)
234. Kim, Y. C.; Masutani, H.; Yamaguchi, Y.; Itoh, K.; Yamamoto, M.; Yodoi, J. Hemin-induced activation of the thioredoxin gene by Nrf2. A differential regulation of the antioxidant responsive element by a switch of its binding factors. J. Biol. Chem. 2001, 276, 18399-18406.
235. Dhakshinamoorthy, S.; Jaiswal, A. K. Functional characterization and role of INrf2 in antioxidant response element-mediated expression and antioxidant induction of NAD (P) H: quinone oxidoreductase1 gene. Oncogene 2001, 20, 3906-3917. (Pubitemid 32646201)
236. Hayes, J. D.; McMahon, M. Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention. Cancer Lett. 2001, 174, 103-113. (Pubitemid 33026113)
237. Kwak, M. K.; Egner, PA.; Dolan, P. M.; Ramos-Gomez, M.; Groopman, J. D.; Itoh, K.; Yamamoto, M.; Kensler, T. W. Role of phase 2 enzyme induction in chemoprotection by dithiolethiones. Mutat. Res. 2001, 480-481, 305-315. (Pubitemid 32744837)
238. Kong, A. N.; Owuor, E.; Yu, R.; Hebbar, V.; Chen, C.; Hu, R.; Mandlekar, S. Induction of xenobiotic enzymes by the MAP kinase pathway and the antioxidant or electrophile response element (ARE/EpRE). Drug Metab. Rev. 2001, 33, 255-271. (Pubitemid 33136265)
239. Xu, C.; Li, C. Y.; Kong, A. N. Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch. Pharm. Res. 2005, 28, 249-268. (Pubitemid 44698742)
240. Morimitsu, Y.; Nakagawa, Y.; Hayashi, K.; Fujii, H.; Kumagai, T.; Nakamura, Y.; Osawa, T.; Horio, F.; Itoh, K.; Iida, K.; et al. A sulforaphane analogue that potently activates the Nrf2-dependent detoxification pathway. J. Biol. Chem. 2002, 277, 3456-3463. (Pubitemid 34953214)
241. Angel, P.; Karin, M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1991, 1072, 129-157. (Pubitemid 121007534)
242. Albanese, C.; Johnson, J.; Watanabe, G.; Eklund, N.; Vu, D.; Arnold, A.; Pestell, R. G. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 1995, 270, 23589-23597.
243. Palozza, P.; Parrone, N.; Catalano, A.; Simone, R. Tomato lycopene and inflammatory cascade: Basic interactions and clinical implications. Curr. Med. Chem. 2010, 17, 2547-2563.
244. Polakis, P. Wnt signaling and cancer. Genes Dev. 2000, 14, 1837-1851. (Pubitemid 30639518)
245. Schulenburg, A.; Cech, P.; Herbacek, I.; Marian, B.; Wrba, F.; Valent, P.; Ulrich-Pur, H. CD44-positive colorectal adenoma cells express the potential stem cell markers musashi antigen (msi1) and ephrin B2 receptor (EphB2). J. Pathol. 2007, 213, 152-160. (Pubitemid 47612237)
246. Cohen, P.; Frame, S. The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2001, 2, 769-776. (Pubitemid 33679839)
247. Korkaya, H.; Paulson, A.; Charafe-Jauffret, E.; Ginestier, C.; Brown, M.; Dutcher, J.; Clouthier, S. G.; Wicha, M. S. Regulation of mammary stem/progenitor cells by PTEN/Akt/β-catenin signaling. PLoS Biol. 2009, 7, e1000121.
248. Tang, F. Y.; Shih, C. J.; Cheng, L. H.; Ho, H. J.; Chen, H. J. Lycopene inhibits growth of human colon cancer cells via suppression of the Akt signaling pathway. Mol. Nutr. Food Res. 2008, 52, 646-654.
249. Lin, M. C.; Wang, F. Y.; Kuo, Y. H.; Tang, F. Y. Cancer chemopreventive effects of lycopene: Suppression of MMP-7 expression and cell invasion in human colon cancer cells. J. Agric. Food Chem. 2011, 59, 11304-11318.
250. Tanaka, T.; Suzuki, R. Inflammation and cancer. In Cancer: Disease Progression and Chemoprevention; Tanaka, T., Ed.; Research Signpost: Kerala, India, 2007; pp. 27-44.
251. Tanaka, T.; Kohno, H.; Suzuki, R.; Yamada, Y.; Sugie, S.; Mori, H. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci. 2003, 94, 965-973. (Pubitemid 37508979)
252. Kim, H. Inhibitory mechanism of lycopene on cytokine expression in experimental pancreatitis. Ann. N. Y. Acad. Sci. 2011, 1229, 99-102.
253. Erkan, M.; Reiser-Erkan, C.; Michalski, C. W.; Kleeff, J. Tumor microenvironment and progression of pancreatic cancer. Exp. Oncol. 2010, 32, 128-131.
254. Nitsche, C.; Simon, P.; Weiss, F. U.; Fluhr, G.; Weber, E.; Gartner, S.; Behn, C. O.; Kraft, M.; Ringel, J.; Aghdassi, A.; et al. Environmental risk factors for chronic pancreatitis and pancreatic cancer. Dig. Dis. 2011, 29, 235-242.
255. Gallicchio, L.; Boyd, K.; Matanoski, G.; Tao, X. G.; Chen, L.; Lam, T. K.; Shiels, M.; Hammond, E.; Robinson, K. A.; Caulfield, L. E.; et al. Carotenoids and the risk of developing lung cancer: A systematic review. Am. J. Clin Nutr. 2008, 88, 372-383.